Approximately one third of people with Psoriasis report being diagnosed before age 20. The prevalence of the disease in childhood and adolescence ranges between 0.5% and 2%. According to the World Psoriasis Day consortium 125 million people worldwide have Psoriasis. Psoriasis affects about 6.7 million Americans and is estimated to affect 2–4% of the population […]

Read More →

Thailand is the second largest healthcare market in Southeast Asia after Indonesia making up roughly about 20% of the region’s expenditure. Thailand’s pharmaceutical market is the eight largest in the Asia Pacific region and considered as one of the largest and most developed in ASEAN. Why choose Thailand as your Generic Drug Market? Thailand’s Generic market presents […]

Read More →

Singapore is considered as the R&D pioneer in Asia with highly qualified clinicians, a solid and advanced infrastructure, cutting-edge technology, commitment by the government to become one of the preferred clinical research destinations worldwide. Singapore is central to the region (South East Asia) and hub of the life sciences industry, acting as a pacesetter to […]

Read More →

Ukraine, the eighth largest European country by population, has often been overlooked as a clinical trial site, yet remains an attractive location for multinational companies for its clinical studies potential. Ukraine is one of the most attractive regions of the post-Soviet area in terms of clinical research because of its vast population which is concentrated […]

Read More →

Japan is the world’s second-largest single-country pharmaceutical market, accounting for approximately 10 percent of global drug sales and expanding quickly. Top foreign pharmaceutical companies operating in Japan enjoy annual growth rates from 12 to 31 percent, rivaling the expansion observed in emerging markets. This growth spurt has been largely attributed to the Japanese government’s multi-year […]

Read More →

Russia has become an increasingly attractive venue for conducting clinical trials for international pharmaceutical companies. Russian clinics and principal investigators have proven to be highly capable of conducting clinical research at a level of quality not less than that of investigators in Western Europe and North America. Why Clinical Trials in Russia? Sponsors are considering […]

Read More →

Rosacea is a common chronic inflammatory skin condition that causes redness and visible blood vessels on face. It may also produce small, red, pus-filled bumps. Rosacea can be mistaken for acne, eczema, or a skin allergy. In US more than 14 million people are estimated living with Rosacea. What is Rosacea? Rosacea is a long-term […]

Read More →

China has brought significant reforms in its regulatory system for pharmaceutical industry and clinical trials. In its continuous drive to improve the system, recently China’s Food and Drug Administration (CFDA) announced a major overhaul of its medical device regulations as well. To the current regulations, China has made significant changes. Summarily, 12 articles were newly […]

Read More →

Foot ulcers refer to a patch of broken down skin usually on the lower leg or feet. In diabetics, when blood sugar levels are high or fluctuate regularly, skin that would normally heal may not properly repair itself because of nerve damage. therefore start a foot ulcer. It occurs in 15% of people with diabetes, and […]

Read More →

Glomerulonephritis (GN) is a serious kidney disorder that can lead to end-stage renal disease (ESRD), other serious morbidity, or death. Worldwide, IgA Nephropathy (Berger disease) is the most common cause of GN. IgA nephropathy is a autoimmune disease and is one of the most common kidney diseases, other than those caused by diabetes or high […]

Read More →